{
    "organizations": [],
    "uuid": "9671aaefcc9386c3337addc72031dac9d1edaf40",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bracco-diagnostics-receives-fda-ap/brief-bracco-diagnostics-receives-fda-approval-for-use-of-multihance-injection-in-patients-younger-than-2-idUSASB0C2Z6",
    "ord_in_thread": 0,
    "title": "BRIEF-Bracco Diagnostics Receives FDA Approval For Use Of Multihance Injection In Patients Younger Than 2",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Bracco Diagnostics Inc:\n* BRACCO DIAGNOSTICS INC. RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR USE OF MULTIHANCEÂ® (GADOBENATE DIMEGLUMINE) INJECTION, 529 MG/ML IN MAGNETIC RESONANCE IMAGING (MRI) OF THE CENTRAL NERVOUS SYSTEM (CNS) IN PEDIATRIC PATIENTS YOUNGER TH Source text for Eikon:\n ",
    "published": "2018-01-30T21:15:00.000+02:00",
    "crawled": "2018-01-31T16:51:57.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "bracco",
        "diagnostics",
        "inc",
        "bracco",
        "diagnostics",
        "receives",
        "food",
        "drug",
        "administration",
        "fda",
        "approval",
        "use",
        "gadobenate",
        "dimeglumine",
        "injection",
        "magnetic",
        "resonance",
        "imaging",
        "mri",
        "central",
        "nervous",
        "system",
        "cns",
        "pediatric",
        "patient",
        "younger",
        "th",
        "source",
        "text",
        "eikon"
    ]
}